Transdermal methods and systems for the delivery of anti-migraine compounds

A method for treating a human for a migraine, comprising

• transdermally administering to said human an effective amount of a triptan compound in less than one hour, and
• maintaining an effective steady state plasma concentration of the triptan compound for at least one hour using an integrated iontophoretic patch,
• wherein said patch uses a first current density and a second current density selected such that said first current density and said second current density do not substantially irritate said human's skin, and
• wherein an effective dosage level is reached in said human in less than one hour and a maintenance level is continued for one or more hours,
• such that said human is treated for said migraine.